These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16540671)

  • 1. EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms.
    Pore N; Jiang Z; Gupta A; Cerniglia G; Kao GD; Maity A
    Cancer Res; 2006 Mar; 66(6):3197-204. PubMed ID: 16540671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth factor receptor therapy.
    Secades P; de Santa-María IS; Merlo A; Suarez C; Chiara MD
    Head Neck; 2015 Aug; 37(8):1150-62. PubMed ID: 24798801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nelfinavir down-regulates hypoxia-inducible factor 1alpha and VEGF expression and increases tumor oxygenation: implications for radiotherapy.
    Pore N; Gupta AK; Cerniglia GJ; Jiang Z; Bernhard EJ; Evans SM; Koch CJ; Hahn SM; Maity A
    Cancer Res; 2006 Sep; 66(18):9252-9. PubMed ID: 16982770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulated cyclin D1 expression is associated with decreased efficacy of the selective epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in head and neck squamous cell carcinoma cell lines.
    Kalish LH; Kwong RA; Cole IE; Gallagher RM; Sutherland RL; Musgrove EA
    Clin Cancer Res; 2004 Nov; 10(22):7764-74. PubMed ID: 15570011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.
    Huang S; Armstrong EA; Benavente S; Chinnaiyan P; Harari PM
    Cancer Res; 2004 Aug; 64(15):5355-62. PubMed ID: 15289342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irradiation-induced regulation of plasminogen activator inhibitor type-1 and vascular endothelial growth factor in six human squamous cell carcinoma lines of the head and neck.
    Artman T; Schilling D; Gnann J; Molls M; Multhoff G; Bayer C
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):574-82. PubMed ID: 20117293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells.
    Gao N; Nester RA; Sarkar MA
    Toxicol Appl Pharmacol; 2004 Apr; 196(1):124-35. PubMed ID: 15050414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gefitinib circumvents hypoxia-induced drug resistance by the modulation of HIF-1alpha.
    Rho JK; Choi YJ; Lee JK; Ryoo BY; Na II; Yang SH; Kim CH; Yoo YD; Lee JC
    Oncol Rep; 2009 Mar; 21(3):801-7. PubMed ID: 19212642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cigarette smoke-mediated mucin expression by hypoxia-inducible factor-1α via epidermal growth factor receptor-mediated signaling pathways.
    Yu H; Li Q; Kolosov VP; Perelman JM; Zhou X
    J Appl Toxicol; 2012 Apr; 32(4):282-92. PubMed ID: 21544845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and distinct from that induced by hypoxia.
    Maity A; Pore N; Lee J; Solomon D; O'Rourke DM
    Cancer Res; 2000 Oct; 60(20):5879-86. PubMed ID: 11059786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells.
    Merighi S; Benini A; Mirandola P; Gessi S; Varani K; Simioni C; Leung E; Maclennan S; Baraldi PG; Borea PA
    Mol Pharmacol; 2007 Aug; 72(2):395-406. PubMed ID: 17488804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof].
    Yu ZT; Zhao HF; Shang XB
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2465-9. PubMed ID: 19080625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF-1 induced vascular endothelial growth factor secretion in head and neck squamous cell carcinoma.
    Slomiany MG; Black LA; Kibbey MM; Day TA; Rosenzweig SA
    Biochem Biophys Res Commun; 2006 Apr; 342(3):851-8. PubMed ID: 16499871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib.
    Timpson P; Wilson AS; Lehrbach GM; Sutherland RL; Musgrove EA; Daly RJ
    Cancer Res; 2007 Oct; 67(19):9304-14. PubMed ID: 17909038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ectopic decorin expression up-regulates VEGF expression in mouse cerebral endothelial cells via activation of the transcription factors Sp1, HIF1alpha, and Stat3.
    Santra M; Santra S; Zhang J; Chopp M
    J Neurochem; 2008 Apr; 105(2):324-37. PubMed ID: 18021292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
    Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
    Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
    Chang CM; Chang PY; Tu MG; Lu CC; Kuo SC; Amagaya S; Lee CY; Jao HY; Chen MY; Yang JS
    Oncol Rep; 2012 Nov; 28(5):1799-807. PubMed ID: 22923287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism.
    Pore N; Liu S; Shu HK; Li B; Haas-Kogan D; Stokoe D; Milanini-Mongiat J; Pages G; O'Rourke DM; Bernhard E; Maity A
    Mol Biol Cell; 2004 Nov; 15(11):4841-53. PubMed ID: 15342781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoblast-specific transcription factor Osterix (Osx) and HIF-1α cooperatively regulate gene expression of vascular endothelial growth factor (VEGF).
    Chen D; Tian W; Li Y; Tang W; Zhang C
    Biochem Biophys Res Commun; 2012 Jul; 424(1):176-81. PubMed ID: 22750006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.